CRISPR-Cas9 technology used to study hereditary forms of cancer – Drug Target Review
|
CRISPR-Cas9 technology used to study hereditary forms of cancer
Drug Target Review Researchers have developed a method, based on CRISPR-Cas9 technology in organoids, to study the genetic cause of hereditary forms of cancer, this method can be of great significance for the diagnosis and treatment of multiple forms of cancer. |
